- Home
- Publications
- Publication Search
- Publication Details
Title
Pembrolizumab in recurrent advanced cervical squamous carcinoma
Authors
Keywords
-
Journal
Immunotherapy
Volume 9, Issue 6, Pages 467-470
Publisher
Future Medicine Ltd
Online
2017-04-12
DOI
10.2217/imt-2016-0119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cervical Cancer
- (2017) Benjamin E. Greer et al. Journal of the National Comprehensive Cancer Network
- Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
- (2016) Lucia Festino et al. DRUGS
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- The end of the decline in cervical cancer mortality in Spain: trends across the period 1981–2012
- (2015) Marta Cervantes-Amat et al. BMC CANCER
- SEOM guidelines for cervical cancer
- (2015) A. Oaknin et al. Clinical & Translational Oncology
- Systemic therapy for recurrent, persistent, or metastatic cervical cancer: a clinical practice guideline
- (2015) H. Hirte et al. Current Oncology
- Cervical Carcinoma in the European Union
- (2015) Emma Altobelli et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends of cervical cancer mortality in the member states of the European Union
- (2009) Marc Arbyn et al. EUROPEAN JOURNAL OF CANCER
- Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
- (2009) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started